GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chiome Bioscience Inc (TSE:4583) » Definitions » Cyclically Adjusted Book per Share

Chiome Bioscience (TSE:4583) Cyclically Adjusted Book per Share : 円120.50 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Chiome Bioscience Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Chiome Bioscience's adjusted book value per share for the three months ended in Dec. 2024 was 円28.680. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円120.50 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Chiome Bioscience's average Cyclically Adjusted Book Growth Rate was -8.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Chiome Bioscience was -5.50% per year. The lowest was -5.50% per year. And the median was -5.50% per year.

As of today (2025-05-30), Chiome Bioscience's current stock price is 円146.00. Chiome Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was 円120.50. Chiome Bioscience's Cyclically Adjusted PB Ratio of today is 1.21.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Chiome Bioscience was 2.31. The lowest was 0.81. And the median was 1.18.


Chiome Bioscience Cyclically Adjusted Book per Share Historical Data

The historical data trend for Chiome Bioscience's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chiome Bioscience Cyclically Adjusted Book per Share Chart

Chiome Bioscience Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 142.58 146.03 132.23 120.50

Chiome Bioscience Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136.80 132.23 126.96 122.63 120.50

Competitive Comparison of Chiome Bioscience's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Chiome Bioscience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chiome Bioscience's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chiome Bioscience's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Chiome Bioscience's Cyclically Adjusted PB Ratio falls into.


;
;

Chiome Bioscience Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chiome Bioscience's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=28.68/110.7000*110.7000
=28.680

Current CPI (Dec. 2024) = 110.7000.

Chiome Bioscience Quarterly Data

Book Value per Share CPI Adj_Book
201412 264.974 97.900 299.618
201503 250.097 97.900 282.796
201506 234.073 98.400 263.332
201509 221.753 98.500 249.219
201512 207.033 98.100 233.624
201603 195.335 97.900 220.874
201606 179.856 98.100 202.957
201609 171.173 98.000 193.356
201612 179.339 98.400 201.756
201703 175.607 98.100 198.162
201706 175.899 98.500 197.685
201709 168.985 98.800 189.338
201712 157.484 99.400 175.387
201803 146.262 99.200 163.218
201806 134.973 99.200 150.620
201809 122.608 99.900 135.863
201812 99.948 99.700 110.975
201903 100.586 99.700 111.684
201906 96.846 99.800 107.423
201909 85.727 100.100 94.805
201912 78.764 100.500 86.758
202003 66.065 100.300 72.915
202006 73.280 99.900 81.202
202009 81.217 99.900 89.997
202012 78.723 99.300 87.761
202103 77.380 99.900 85.745
202106 70.956 99.500 78.943
202109 60.252 100.100 66.632
202112 46.420 100.100 51.336
202203 38.989 101.100 42.691
202206 34.283 101.800 37.280
202209 35.894 103.100 38.540
202212 36.981 104.100 39.326
202303 32.260 104.400 34.207
202306 23.599 105.200 24.833
202309 23.950 106.200 24.965
202312 21.996 106.800 22.799
202403 22.392 107.200 23.123
202406 18.987 108.200 19.426
202412 28.680 110.700 28.680

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Chiome Bioscience  (TSE:4583) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Chiome Bioscience's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=146.00/120.50
=1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Chiome Bioscience was 2.31. The lowest was 0.81. And the median was 1.18.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Chiome Bioscience Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Chiome Bioscience's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chiome Bioscience Business Description

Industry
Traded in Other Exchanges
N/A
Address
Sumitomo Fudosan Nishi-shinjuku Building No.6, 3-12-1, Honmachi, Shibuya-ku, Tokyo, JPN, 151-0071
Chiome Bioscience Inc is a Japanese based company engaged in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library System. The business activity of the group is operated through Drug Discovery Alliance, Lead Antibody Licensing, and Licensing Out Platform Technology segments. The Drug Discovery Alliance segment partners with pharmaceutical companies to develop and create lead antibody drugs. The Lead Antibody Licensing Out segment is engaged in the production of specific antibodies against antigens and early licensing out to pharmaceutical manufacturers and the Licensing Out Platform Technology segment conducts research and development through the ADLib System. Geographically all the activities are functioned through Japan.

Chiome Bioscience Headlines

No Headlines